Letter: Somatostatin, growth hormone and parkinsonism.
作者信息
Cotzias G C, Papavasiliou P S
出版信息
N Engl J Med. 1976 Feb 12;294(7):398. doi: 10.1056/nejm197602122940720.
PMID:1246301
Abstract
摘要
相似文献
1
Letter: Somatostatin, growth hormone and parkinsonism.
N Engl J Med. 1976 Feb 12;294(7):398. doi: 10.1056/nejm197602122940720.
2
Treatment of parkinsonism.
Adv Exp Med Biol. 1977;90:49-61. doi: 10.1007/978-1-4684-2511-6_3.
3
Therapeutic approaches in Parkinson's disease: possible roles of growth hormone and somatostatin.帕金森病的治疗方法：生长激素和生长抑素的潜在作用
Res Publ Assoc Res Nerv Ment Dis. 1976;55:305-15.
4
Editorial: Dopa decarboxylase inhibitors.社论：多巴脱羧酶抑制剂
Br Med J. 1974 Nov 2;4(5939):250-1. doi: 10.1136/bmj.4.5939.250.
5
Sinemet and the treatment of Parkinsonism.息宁与帕金森症的治疗
Ann Intern Med. 1981 Mar;94(3):364-70. doi: 10.7326/0003-4819-94-3-364.
6
Effect of L-dopa administration on growth hormone secretion in normal subjects and Parkinsonian patients.
J Endocrinol. 1972 Sep;54(3):425-33. doi: 10.1677/joe.0.0540425.
7
8
Levodopa in the treatment of Parkinsonism.
JAMA. 1971 Dec 27;218(13):1903-8.
9
[Carbidopa-levodopa, growth hormone and parkinsonism].[卡比多巴-左旋多巴、生长激素与帕金森病]
Rev Clin Esp. 1976 Jun 30;141(6):525-32.
10
Effects of somatostatin in parkinsonism, growth hormone, and dopa metabolism.生长抑素在帕金森病、生长激素及多巴代谢中的作用。
Trans Am Neurol Assoc. 1977;102:90-3.
引用本文的文献
1
Properties of soluble somatostatin-binding protein.可溶性生长抑素结合蛋白的特性
Biochem J. 1977 Aug 1;165(2):269-77. doi: 10.1042/bj1650269.
Zotero 插件